Bolt Biotherapeutics Files 8-K for Bylaw Amendments
Ticker: BOLT · Form: 8-K · Filed: Apr 16, 2025 · CIK: 1641281
| Field | Detail |
|---|---|
| Company | Bolt Biotherapeutics, Inc. (BOLT) |
| Form Type | 8-K |
| Filed Date | Apr 16, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing, bylaws
TL;DR
Bolt Bio filed an 8-K for bylaw changes and financials. Nothing major yet.
AI Summary
Bolt Biotherapeutics, Inc. filed an 8-K on April 15, 2025, reporting amendments to its articles of incorporation or bylaws and financial statements. The company, previously known as Bolt Therapeutics, Inc., is incorporated in Delaware and headquartered in Redwood City, California.
Why It Matters
This filing indicates potential corporate governance changes or updates to the company's foundational documents, which could impact its operational structure or shareholder rights.
Risk Assessment
Risk Level: low — The filing is routine and reports standard corporate actions without immediate financial or operational distress.
Key Numbers
- 001-39988 — SEC File Number (Identifies the company's filing with the SEC)
- 47-2804636 — IRS Employer Identification No. (Tax identification number for the company)
Key Players & Entities
- Bolt Biotherapeutics, Inc. (company) — Registrant
- Bolt Therapeutics, Inc. (company) — Former company name
- April 15, 2025 (date) — Date of earliest event reported
- Redwood City, California (location) — Principal Executive Offices
- Delaware (location) — State of Incorporation
FAQ
What specific amendments were made to Bolt Biotherapeutics' articles of incorporation or bylaws?
The filing indicates that amendments were made, but the specific details of these amendments are not provided in the summary text of the 8-K.
When was the company formerly known as Bolt Therapeutics, Inc.?
The company's name was changed from Bolt Therapeutics, Inc. on May 4, 2015.
What is the principal executive office address for Bolt Biotherapeutics, Inc.?
The principal executive offices are located at 900 Chesapeake Drive, Redwood City, California 94063.
What is the SIC code for Bolt Biotherapeutics, Inc.?
The Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
What is the fiscal year end for Bolt Biotherapeutics, Inc.?
The company's fiscal year ends on December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 16, 2025 regarding Bolt Biotherapeutics, Inc. (BOLT).